Orthofix Medical Dividends
| OFIX Stock | USD 13.50 0.12 0.90% |
Dividends Paid is likely to drop to about 1 M in 2026. Dividend Paid And Capex Coverage Ratio is likely to drop to 0.81 in 2026. Orthofix Medical's past performance could be the main factor of why investors trade Orthofix Medical stock today. Investors should clearly understand every aspect of the Orthofix Medical dividend schedule, including its future sustainability, and how it might impact an overall investment strategy. This tool is helpful to digest Orthofix Medical's dividend schedule and payout information. Orthofix Medical dividends can also provide a clue to the current valuation of Orthofix Medical.
| Last Reported | Projected for Next Year | ||
| Dividends Paid | 2 M | 1 M | |
| Dividend Paid And Capex Coverage Ratio | 0.85 | 0.81 |
Investing in stocks that pay dividends is one of many strategies that are good for long-term investments. Ex-dividend dates are significant because investors in Orthofix Medical must own a stock before its ex-dividend date to receive its next dividend.
Orthofix Medical Dividends Paid Over Time
Today, most investors in Orthofix Medical Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Orthofix Medical's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's dividends paid growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Orthofix Medical dividends paid as a starting point in their analysis.
The total amount of dividends that a company has paid out to its shareholders over a specific period. Dividends Paid |
| Timeline |
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Orthofix Medical. Anticipated expansion of Orthofix directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Orthofix Medical assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (3.03) | Revenue Per Share | Quarterly Revenue Growth 0.046 | Return On Assets | Return On Equity |
Orthofix Medical's market price often diverges from its book value, the accounting figure shown on Orthofix's balance sheet. Smart investors calculate Orthofix Medical's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Since Orthofix Medical's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Orthofix Medical's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Orthofix Medical should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Orthofix Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.